Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment.
2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.
Combination Treatment of Interferon β-1b and Warfarin for a Patient With Baló's Concentric Sclerosis and Antiphospholipid Syndrome.
No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis.
Calcitriol Modulates the CD46 Pathway in T Cells.
Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma
Genzyme’s Lemtrada™ approved in Australia for treatment of multiple sclerosis
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study.
Comparing the biological impact of glatiramer acetate with the biological impact of a generic.
Small internal jugular veins with restricted outflow are associated with severe multiple sclerosis: a sonographer-blinded, case--control ultrasound study.
Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis.
Role of the Blood-Brain Barrier in Multiple Sclerosis.
The Many Facets of Cell Injury: Angiogenesis to Autophagy.
[The Sjögren's syndrome and multiple sclerosis: similarity and differences.]
[Infections and fingolimod].
Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis.
Dopaminergic Modulation of CD4+CD25 Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy.
Pediatric multiple sclerosis.
A systematic review of research undertaken in vocational rehabilitation for people with multiple sclerosis.
Stress Management and Multiple Sclerosis: A Randomized Controlled Trial.
Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis.
Puma, but not noxa is essential for oligodendroglial cell death.
English Court of Appeal finds in favor of Teva on Copaxone(R) patent litigation and upholds validity of Copaxone patent until May 2015
Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.
RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis.

Pages